NCT06243510 2026-01-28
CARE
Abramson Cancer Center at Penn Medicine
Phase NA Enrolling by invitation
Clinical Trials
43 trialsNCT07270263 2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA Recruiting
NCT05255003 2025-12-17
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT07189897 2025-10-08
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
State University of New York - Upstate Medical University
Phase 4 Recruiting
NCT03244020 2025-10-03
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Massachusetts General Hospital
Phase 4 Enrolling by invitation
NCT07132515 2025-08-20
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
Phase 4 Recruiting
NCT04731558 2025-02-14
PREPOSTEROUS
Helsinki University Central Hospital
Phase 4 Recruiting
NCT05245877 2025-02-14
PREPOSTEROUS2
Helsinki University Central Hospital
Phase 4 Recruiting
NCT03532139 2025-01-23
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT06049758 2023-09-22
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
General Committee of Teaching Hospitals and Institutes, Egypt
Phase NA Not yet recruiting
NCT01583218 2023-08-07
APEX
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT01999179 2022-05-18
Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis
Medical College of Wisconsin
Phase NA Completed
NCT04999176 2021-08-10
VALERIA
Science Valley Research Institute
Phase 3 Unknown
NCT02444572 2021-07-29
ENOXACARE
Les Laboratoires des Médicaments Stériles
Phase 4 Completed
NCT02706249 2021-07-08
Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00633061 2020-10-08
DVT
University of Texas Southwestern Medical Center
Phase 2 Terminated
NCT01763606 2020-08-14
Enoxaparin Versus Aspirin in Patients With Cancer and Stroke
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01839487 2020-07-20
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
Halozyme Therapeutics
Phase 2 Completed
NCT04462003 2020-07-08
DVT
Beni-Suef University
Phase 3 Unknown
NCT02366871 2020-03-31
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
Phase 2 Completed
NCT02589145 2019-12-13
Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT01727427 2019-08-08
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
G. d'Annunzio University
Completed
NCT01696760 2018-12-05
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Phase NA Completed
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT01058759 2018-08-22
Taxotere-Enoxaparin-(ENOXA)-Study
Hannover Medical School
Phase 3 Terminated
NCT03570281 2018-06-26
ENCHASE
Samsung Medical Center
Phase 2/3 Unknown
NCT01965002 2018-05-23
Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
Stanford University
Phase NA Terminated
NCT00426127 2017-12-29
Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer
University of Iowa
Phase 2 Terminated
NCT00908960 2017-12-19
MicroTEC
Dana-Farber Cancer Institute
Phase 2 Completed
NCT01149304 2017-11-20
ELDORADO
University of Magdeburg
Phase 2 Completed
NCT00717938 2017-08-25
RASTEN
Lund University Hospital
Phase 3 Completed
NCT01444612 2017-05-16
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
GlaxoSmithKline
Completed
NCT01356329 2016-05-13
Lovenox
National Guard Health Affairs
Phase 3 Suspended
NCT00718354 2015-05-13
GASTRANOX
Thrombosis Research Institute
Phase 3 Completed
NCT00785421 2015-01-08
PROSPECT
CONKO-Studiengruppe
Phase 2/3 Completed
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated
NCT01945879 2013-09-19
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
CONKO-Studiengruppe
Phase 1/2 Completed
NCT00771563 2013-06-28
SYRINGES
University Hospital, Antwerp
Phase 3 Completed
NCT00916669 2013-05-08
A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)
Massachusetts General Hospital
Phase 2 Withdrawn
NCT00004875 2011-02-21
Heparin or Enoxaparin in Patients With Cancer
Northwestern University
Completed
NCT00723216 2010-04-05
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Sanofi
Phase 3 Completed
NCT00375076 2009-09-18
Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients
Medical University of Vienna
Phase 3 Completed